Suchergebnisse - "Horvath, Zsolt"

PubPharm (215)

1

Structural Control Enables Catalytic and Electrocatalytic Activity of Porous Tetrametallic Nanorods

enthalten in: Small (Weinheim an der Bergstrasse, Germany) | 2024

von Zámbó, D. | Kovács, D. | Radnóczi, G. | +4

2

Amorphous, Carbonated Calcium Phosphate and Biopolymer-Composite-Coated Si3N4/MWCNTs as Potential Novel Implant Materials

enthalten in: Nanomaterials (Basel, Switzerland) | 2024

von Furko, M. | Detsch, R. | Horváth, Z. | +3

3

The relationship between alcohol use and self-determination:psychometric characteristics of the Treatment Self-Regulation Questionnaire in a Hungarian sample

enthalten in: Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology | 2023

von Boda, L. | Horvath, Z.

4

Histopathology-assisted proteogenomics provides foundations for stratification of melanoma metastases

enthalten in: bioRxiv.org | 2023

von Kuras, M. | Betancourt, L. | Hong, R. | +28

5

Simultaneous Comparisons of 25 Acute Migraine Medications Based on 10 Million Users' Self-Reported Records From a Smartphone Application

enthalten in: Neurology | 2023

von Chiang, C. | Fang, X. | Horvath, Z. | +6

6

The Predictive Role of Tolerance and Health Problems in Problem Gambling : A Cross-Sectional and Cross-Lagged Network Analyses

enthalten in: Journal of gambling studies | 2023

von Horváth, Z. | Paksi, B. | Fernández-Aranda, F. | +2

7

Religious status and addictive behaviors : Exploring patterns of use and psychological proneness

enthalten in: Comprehensive psychiatry | 2023

von Kádár, B. | Péter, L. | Paksi, B. | +7

8

Psychometric properties of the Alcohol Use Disorders Identification Test (AUDIT) across cross-cultural subgroups, genders, and sexual orientations : Findings from the International Sex Survey (ISS)

enthalten in: Comprehensive psychiatry | 2023

von Horváth, Z. | Nagy, L. | Koós, M. | +66

9

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859) : a multicentre, randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2023

von Rha, S. | Oh, D. | Yañez, P. | +121

10

HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection : final results of a nationwide screening program

enthalten in: European radiology | 2023

von Kerpel-Fronius, A. | Megyesfalvi, Z. | Markóczy, Z. | +42

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]